124 related articles for article (PubMed ID: 17129982)
1. Determinants of compliance with methylphenidate therapy in children.
Hugtenburg JG; Witte I; Heerdink ER
Acta Paediatr; 2006 Dec; 95(12):1674-6. PubMed ID: 17129982
[TBL] [Abstract][Full Text] [Related]
2. An analysis of patient adherence to treatment during a 1-year, open-label study of OROS methylphenidate in children with ADHD.
Faraone SV; Biederman J; Zimmerman B
J Atten Disord; 2007 Sep; 11(2):157-66. PubMed ID: 17494833
[TBL] [Abstract][Full Text] [Related]
3. [Sociodemographic and clinical factors associated with compliance to methylphenidate treatment in children with attention deficit hyperactivity disorder].
Kiliç BG; Bilgiç A; Gürkan K; Aysev A
Turk Psikiyatri Derg; 2007; 18(3):207-13. PubMed ID: 17853975
[TBL] [Abstract][Full Text] [Related]
4. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
6. [Use of methylphenidate among children in Iceland 1989-2006].
Zoëga H; Baldursson G; Halldórsson M
Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
[TBL] [Abstract][Full Text] [Related]
7. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
[TBL] [Abstract][Full Text] [Related]
8. Children's self-reports on perceived effects on taking stimulant medication for ADHD.
Thorell LB; Dahlström K
J Atten Disord; 2009 Mar; 12(5):460-8. PubMed ID: 18685139
[TBL] [Abstract][Full Text] [Related]
9. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
10. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate: use in daily practice.
Hugtenburg JG; Griekspoor JE; De Boer I; Heerdink ER; Tso YH; Egberts AC
Pharm World Sci; 2005 Jun; 27(3):197-201. PubMed ID: 16096887
[TBL] [Abstract][Full Text] [Related]
12. [Methylphenidate double-blind trial: indication and performing].
Bliznakova L; Gerstner S; Schmidt MH; Becker K
Klin Padiatr; 2007; 219(1):9-16. PubMed ID: 17205427
[TBL] [Abstract][Full Text] [Related]
13. An 8-year follow-up study of profiles and predictors of methylphenidate use in a nationwide sample of boys.
Romano E; Thornhill S; Lacourse E
J Pediatr; 2009 Nov; 155(5):721-7. PubMed ID: 19643442
[TBL] [Abstract][Full Text] [Related]
14. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
Flapper BC; Schoemaker MM
Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
[TBL] [Abstract][Full Text] [Related]
15. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
16. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
17. Risperidone-to-methylphenidate switch reaction in children: three cases.
Sabuncuoglu O
J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
[TBL] [Abstract][Full Text] [Related]
18. Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users.
Darredeau C; Barrett SP; Jardin B; Pihl RO
Hum Psychopharmacol; 2007 Dec; 22(8):529-36. PubMed ID: 17910020
[TBL] [Abstract][Full Text] [Related]
19. Critical influences affecting response to various treatments in young children with ADHD: a case series.
Heriot SA; Evans IM; Foster TM
Child Care Health Dev; 2008 Jan; 34(1):121-33. PubMed ID: 18171453
[TBL] [Abstract][Full Text] [Related]
20. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
